Since the passing of Professor Emeritus Alan Mackay-Sim AM in 2023, his ground-breaking legacy research is about to be realised with a Phase I human clinical trial commencing to test the efficacy and ...
Prof. Tal Dvir, Head of the Sagol Center for Regenerative Biotechnology, Head of the Nanotechnology Center at Tel Aviv University, and Chief Scientist of the biotech company Matricelf. The surgery is ...
Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback